These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32209625)

  • 1. G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial).
    Salamone P; Fuda G; Casale F; Marrali G; Lunetta C; Caponnetto C; Mazzini L; La Bella V; Mandrioli J; Simone IL; Moglia C; Calvo A; Tarella C; Chio A;
    BMJ Open; 2020 Mar; 10(3):e034049. PubMed ID: 32209625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).
    Mandrioli J; Crippa V; Cereda C; Bonetto V; Zucchi E; Gessani A; Ceroni M; Chio A; D'Amico R; Monsurrò MR; Riva N; Sabatelli M; Silani V; Simone IL; Sorarù G; Provenzani A; D'Agostino VG; Carra S; Poletti A
    BMJ Open; 2019 May; 9(5):e028486. PubMed ID: 31152038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial).
    Mandrioli J; D'Amico R; Zucchi E; Gessani A; Fini N; Fasano A; Caponnetto C; Chiò A; Dalla Bella E; Lunetta C; Mazzini L; Marinou K; Sorarù G; de Biasi S; Lo Tartaro D; Pinti M; Cossarizza A;
    Medicine (Baltimore); 2018 Jun; 97(24):e11119. PubMed ID: 29901635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol of RESCUE-ALS: A Phase 2,
    Vucic S; Kiernan MC; Menon P; Huynh W; Rynders A; Ho KS; Glanzman R; Hotchkin MT
    BMJ Open; 2021 Jan; 11(1):e041479. PubMed ID: 33431491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant).
    Vucic S; Ryder J; Mekhael L; Rd H; Mathers S; Needham M; Dw S; Mc K;
    Medicine (Baltimore); 2020 Feb; 99(6):e18904. PubMed ID: 32028398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial.
    Urbi B; Broadley S; Bedlack R; Russo E; Sabet A
    BMJ Open; 2019 Nov; 9(11):e029449. PubMed ID: 31719072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial).
    Morimoto S; Takahashi S; Fukushima K; Saya H; Suzuki N; Aoki M; Okano H; Nakahara J
    Regen Ther; 2019 Dec; 11():143-166. PubMed ID: 31384636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial.
    Kim S; Kim JK; Son MJ; Kim D; Song B; Son I; Kang HW; Lee J; Kim S
    Trials; 2018 Apr; 19(1):225. PubMed ID: 29653550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.
    Tarella C; Rutella S; Gualandi F; Melazzini M; Scimè R; Petrini M; Moglia C; Ulla M; Omedé P; Bella VL; Corbo M; Silani V; Siciliano G; Mora G; Caponnetto C; Sabatelli M; Chiò A;
    Cytotherapy; 2010; 12(1):50-9. PubMed ID: 19878077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial).
    Bella ED; Tramacere I; Antonini G; Borghero G; Capasso M; Caponnetto C; Chiò A; Corbo M; Eleopra R; Filosto M; Giannini F; Granieri E; Bella V; Lunetta C; Mandrioli J; Mazzini L; Messina S; Monsurrò MR; Mora G; Riva N; Rizzi R; Siciliano G; Silani V; Simone I; Sorarù G; Volanti P; Lauria G
    BMJ Open; 2017 Aug; 7(8):e015434. PubMed ID: 28801400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of Lenzumestrocel (Neuronata-R® inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial.
    Nam JY; Lee TY; Kim K; Chun S; Kim MS; Shin JH; Sung JJ; Kim BJ; Kim BJ; Oh KW; Kim KS; Kim SH
    Trials; 2022 May; 23(1):415. PubMed ID: 35585556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31].
    Al-Chalabi A; Shaw PJ; Young CA; Morrison KE; Murphy C; Thornhill M; Kelly J; Steen IN; Leigh PN;
    BMC Neurol; 2011 Sep; 11():111. PubMed ID: 21936930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial.
    Duning T; Schiffbauer H; Warnecke T; Mohammadi S; Floel A; Kolpatzik K; Kugel H; Schneider A; Knecht S; Deppe M; Schäbitz WR
    PLoS One; 2011 Mar; 6(3):e17770. PubMed ID: 21423758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients.
    Imamura K; Izumi Y; Banno H; Uozumi R; Morita S; Egawa N; Ayaki T; Nagai M; Nishiyama K; Watanabe Y; Hanajima R; Oki R; Fujita K; Takahashi N; Ikeda T; Shimizu A; Morinaga A; Hirohashi T; Fujii Y; Takahashi R; Inoue H
    BMJ Open; 2019 Dec; 9(12):e033131. PubMed ID: 31796494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study.
    Nefussy B; Artamonov I; Deutsch V; Naparstek E; Nagler A; Drory VE
    Amyotroph Lateral Scler; 2010; 11(1-2):187-93. PubMed ID: 19449238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial.
    Beghi E; Pupillo E; Bianchi E; Bonetto V; Luotti S; Pasetto L; Bendotti C; Tortarolo M; Sironi F; Camporeale L; Sherman AV; Paganoni S; Scognamiglio A; De Marchi F; Bongioanni P; Del Carratore R; Caponnetto C; Diamanti L; Martinelli D; Calvo A; Filosto M; Padovani A; Piccinelli SC; Ricci C; Dalla Giacoma S; De Angelis N; Inghilleri M; Spataro R; La Bella V; Logroscino G; Lunetta C; Tarlarini C; Mandrioli J; Martinelli I; Simonini C; Zucchi E; Monsurrò MR; Ricciardi D; Trojsi F; Riva N; Filippi M; Simone IL; Sorarù G; Spera C; Florio L; Messina S; Russo M; Siciliano G; Conte A; Saddi MV; Carboni N; Mazzini L;
    Eur J Neurol; 2023 Jan; 30(1):69-86. PubMed ID: 36148821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study.
    Chiò A; Mora G; La Bella V; Caponnetto C; Mancardi G; Sabatelli M; Siciliano G; Silani V; Corbo M; Moglia C; Calvo A; Mutani R; Rutella S; Gualandi F; Melazzini M; Scimè R; Petrini M; Bondesan P; Garbelli S; Mantovani S; Bendotti C; Tarella C;
    Muscle Nerve; 2011 Feb; 43(2):189-95. PubMed ID: 21254083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction": study protocol for a randomized controlled trial.
    von Lewinski D; Selvanayagam JB; Schatz RA; Jilma B; Kubica J; Povsic TJ; Nix D; Henauer S; Wallner M;
    Trials; 2020 Aug; 21(1):744. PubMed ID: 32843081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury.
    Koda M; Hanaoka H; Sato T; Fujii Y; Hanawa M; Takahashi S; Furuya T; Ijima Y; Saito J; Kitamura M; Ohtori S; Matsumoto Y; Abe T; Watanabe K; Hirano T; Ohashi M; Shoji H; Mizouchi T; Takahashi I; Kawahara N; Kawaguchi M; Orita Y; Sasamoto T; Yoshioka M; Fujii M; Yonezawa K; Soma D; Taneichi H; Takeuchi D; Inami S; Moridaira H; Ueda H; Asano F; Shibao Y; Aita I; Takeuchi Y; Mimura M; Shimbo J; Someya Y; Ikenoue S; Sameda H; Takase K; Ikeda Y; Nakajima F; Hashimoto M; Ozawa T; Hasue F; Fujiyoshi T; Kamiya K; Watanabe M; Katoh H; Matsuyama Y; Yamamoto Y; Togawa D; Hasegawa T; Kobayashi S; Yoshida G; Oe S; Banno T; Arima H; Akeda K; Kawamoto E; Imai H; Sakakibara T; Sudo A; Ito Y; Kikuchi T; Osaki S; Tanaka N; Nakanishi K; Kamei N; Kotaka S; Baba H; Okudaira T; Konishi H; Yamaguchi T; Ito K; Katayama Y; Matsumoto T; Matsumoto T; Idota M; Kanno H; Aizawa T; Hashimoto K; Eto T; Sugaya T; Matsuda M; Fushimi K; Nozawa S; Iwai C; Taguchi T; Kanchiku T; Suzuki H; Nishida N; Funaba M; Yamazaki M
    BMJ Open; 2018 May; 8(5):e019083. PubMed ID: 29730616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled study of Iranian patients.
    Amirzagar N; Nafissi S; Tafakhori A; Modabbernia A; Amirzargar A; Ghaffarpour M; Siroos B; Harirchian MH
    J Clin Neurol; 2015 Apr; 11(2):164-71. PubMed ID: 25851895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.